CCRC Medtech (Shanghai) Co., Ltd
CCRC Medtech (Shanghai) Co., Ltd., founded in 2015, is a clinical research organization (CRO) specializing in the field of medical device technology (i.e., medical devices, in vitro diagnostics, and AI technology). We have provided professional services on clinical studies for a number of well-known domestic and foreign medical device companies, and established a long-term close cooperative relationship with many clinical sites and investigators with rich experience in clinical trial projects in therapeutic fields such as cardiovascular intervention, neurointervention, oncology, respiratory intervention, artificial intelligence, robotics, orthopedics, dentistry, and dermatology.
CCRC is committed to providing customers with
one-stop services throughout the life cycle of device technology R & D
With the headquarter in Shanghai and an office in Beijing, we have nearly 300 employees providing service for more than 30 cities across China. All the members of our core management team have working experience in international first-line CROs or renowned device companies, with an average clinical experience of more than 15 years. CCRC is committed to providing customers with one-stop services throughout the life cycle of device technology R&D, and our services cover from pre-marketing R&D, clinical trial and registration to post-marketing, including clinical monitoring, project management, medical affairs, core laboratory, site management, biostatistics, data management, regulatory affairs, device safety management, medical translation, etc.
Medical Affairs & Safety Management
Imaging Core Lab
High-tech Enterprise Certificate
Certified to ISO 9001
Member of China Association For Medical Devices Industry
Shanghai "specialized and special new" small and medium enterprises
Hygeia Capital was founded by Mr. Wang Kai in 2016 and is headquartered in Shanghai. It is a private equity investment fund and venture capital fund management institution that implements market-oriented operation and is based on the two-wheeled investment strategy of "active investment" + "in-depth investment banking service", focusing on the medical and health industry.